Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanja Fehm

Showing results (131-140 of 390) with videos related to

Pageof 39
Sort By:
Menopause (New York, N.Y.)|October 18, 2016
Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancerXiangyan Ruan, Ying Zhang, Alfred O Mueck, et al.
Breast Cancer Research and Treatment|October 25, 2019
Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patientsMalgorzata Banys-Paluchowski, Karin Milde-Langosch, Tanja Fehm, et al.
BMC Cancer|July 27, 2016
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patientsBahriye Aktas, Sabine Kasimir-Bauer, Volkmar Müller, et al.
Cancers|December 17, 2024
Circulating Tumor DNA in Early and Metastatic Breast Cance-Current Role and What Is Coming NextChristian Martin Tegeler, Andreas Daniel Hartkopf, Maggie Banys-Paluchowski, et al.
Reproductive Biology and Endocrinology : RB&E|February 2, 2024
Progesterone-induced progesterone receptor membrane component 1 rise-to-decline changes are essential for decidualizationHailun Liu, André Franken, Alexandra P Bielfeld, et al.
Geburtshilfe Und Frauenheilkunde|April 20, 2019
Postpartum Depressive Disorder - Psychosomatic AspectsStephanie Schipper-Kochems, Tanja Fehm, Gabriele Bizjak, et al.
Macromolecular Rapid Communications|September 24, 2025
Enrichment of Hyaluronic Acid Binding Tumor Cells by Modulation of Selective Adhesion on Microgel SurfacesMelanie Schmidt, Dilay Karayel, André Franken, et al.
Journal of Cancer Research and Clinical Oncology|March 20, 2021
Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2- breast cancer resistant to endocrine therapy: VinoMetro-AGO-B-046Slavomir Krajnak, Thomas Decker, Lukas Schollenberger, et al.
Menopause (New York, N.Y.)|May 3, 2011
The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cellsHans Neubauer, Yang Yang, Harald Seeger, et al.
Breast Care (Basel, Switzerland)|April 16, 2011
Clinical Recommendations of DEGRO and AGO on Preferred Standard Palliative Radiotherapy of Bone and Cerebral Metastases, Metastatic Spinal Cord Compression, and Leptomeningeal Carcinomatosis in Breast CancerRainer Souchon, Petra Feyer, Christoph Thomssen, et al.
Pageof 39

Showing results (131-140 of 390) with videos related to

Sort By:
Pageof 39
Menopause (New York, N.Y.)|October 18, 2016
Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancerXiangyan Ruan, Ying Zhang, Alfred O Mueck, et al.
Breast Cancer Research and Treatment|October 25, 2019
Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patientsMalgorzata Banys-Paluchowski, Karin Milde-Langosch, Tanja Fehm, et al.
BMC Cancer|July 27, 2016
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patientsBahriye Aktas, Sabine Kasimir-Bauer, Volkmar Müller, et al.
Cancers|December 17, 2024
Circulating Tumor DNA in Early and Metastatic Breast Cance-Current Role and What Is Coming NextChristian Martin Tegeler, Andreas Daniel Hartkopf, Maggie Banys-Paluchowski, et al.
Reproductive Biology and Endocrinology : RB&E|February 2, 2024
Progesterone-induced progesterone receptor membrane component 1 rise-to-decline changes are essential for decidualizationHailun Liu, André Franken, Alexandra P Bielfeld, et al.
Geburtshilfe Und Frauenheilkunde|April 20, 2019
Postpartum Depressive Disorder - Psychosomatic AspectsStephanie Schipper-Kochems, Tanja Fehm, Gabriele Bizjak, et al.
Macromolecular Rapid Communications|September 24, 2025
Enrichment of Hyaluronic Acid Binding Tumor Cells by Modulation of Selective Adhesion on Microgel SurfacesMelanie Schmidt, Dilay Karayel, André Franken, et al.
Journal of Cancer Research and Clinical Oncology|March 20, 2021
Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2- breast cancer resistant to endocrine therapy: VinoMetro-AGO-B-046Slavomir Krajnak, Thomas Decker, Lukas Schollenberger, et al.
Menopause (New York, N.Y.)|May 3, 2011
The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cellsHans Neubauer, Yang Yang, Harald Seeger, et al.
Breast Care (Basel, Switzerland)|April 16, 2011
Clinical Recommendations of DEGRO and AGO on Preferred Standard Palliative Radiotherapy of Bone and Cerebral Metastases, Metastatic Spinal Cord Compression, and Leptomeningeal Carcinomatosis in Breast CancerRainer Souchon, Petra Feyer, Christoph Thomssen, et al.
Pageof 39